Edwards (EW) Accepts Coverage Curbs on Heart Valves; Bloomberg Says Rules Could Cut US Sales by $100M
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Join SI Premium – FREE
Bloomberg reporting Edwards Lifesciences (NYSE: EW) has accepted the US coverage curbs on heart valves. Bloomberg is saying the coverage rules could cut Edwards' US sales of devices by $100 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
- Greenland approves rare earths license transfer to Greenland Mines
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
